AR089857A1 - Comprimido antiacido para refrescar el aliento - Google Patents

Comprimido antiacido para refrescar el aliento

Info

Publication number
AR089857A1
AR089857A1 ARP130100289A ARP130100289A AR089857A1 AR 089857 A1 AR089857 A1 AR 089857A1 AR P130100289 A ARP130100289 A AR P130100289A AR P130100289 A ARP130100289 A AR P130100289A AR 089857 A1 AR089857 A1 AR 089857A1
Authority
AR
Argentina
Prior art keywords
tocopherol
tablet
breath
anticide
cool
Prior art date
Application number
ARP130100289A
Other languages
English (en)
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Publication of AR089857A1 publication Critical patent/AR089857A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Abstract

Comprimido oral antiácido que comprende al menos aproximadamente 60% en peso de carbonato de calcio granulado directamente compresible y un saporífero intenso. El comprimido puede tener una dureza de al menos aproximadamente 22 unidades Strong-Cobb y el comprimido puede tener una masa de entre aproximadamente 500 mg y aproximadamente 1.000 mg. Los comprimidos de la presente reducen o eliminan los síntomas de la acidez estomacal y también refrescan el aliento. Reivindicación 3: El comprimido de la reivindicación 2, en el que el antioxidante es a tocoferol, b tocoferol, g tocoferol, d tocoferol, o una combinación de estos.
ARP130100289A 2012-02-02 2013-01-30 Comprimido antiacido para refrescar el aliento AR089857A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261594055P 2012-02-02 2012-02-02

Publications (1)

Publication Number Publication Date
AR089857A1 true AR089857A1 (es) 2014-09-24

Family

ID=48905820

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130100289A AR089857A1 (es) 2012-02-02 2013-01-30 Comprimido antiacido para refrescar el aliento

Country Status (12)

Country Link
US (1) US20140037759A1 (es)
EP (1) EP2809331A4 (es)
CN (1) CN104136033A (es)
AR (1) AR089857A1 (es)
BR (1) BR112014019155A8 (es)
CA (1) CA2863389A1 (es)
CO (1) CO7020922A2 (es)
HK (1) HK1201179A1 (es)
IN (1) IN2014DN06198A (es)
MX (1) MX2014009391A (es)
WO (1) WO2013116477A1 (es)
ZA (1) ZA201405354B (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU9202318D0 (en) * 1991-07-22 1992-10-28 Bristol Myers Squibb Co Method for preparing medical preparatives containing didesoxi-purine nucleoside
GB9825033D0 (en) * 1998-11-13 1999-01-13 Nycomed Pharma As Process
US6358526B1 (en) * 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom
WO2004064719A2 (en) * 2003-01-24 2004-08-05 State Of Israel, Ministry Of Agriculture Synergistic compositions and methods for potentiating anti-oxidative activity
US20040162333A1 (en) * 2003-02-19 2004-08-19 Naima Mezaache Rapid absorption selective 5-HT agonist formulations
UA95093C2 (uk) * 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
WO2007134158A2 (en) * 2006-05-12 2007-11-22 Drugtech Corporation Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy

Also Published As

Publication number Publication date
BR112014019155A2 (es) 2017-06-20
WO2013116477A1 (en) 2013-08-08
CN104136033A (zh) 2014-11-05
ZA201405354B (en) 2015-11-25
IN2014DN06198A (es) 2015-10-23
MX2014009391A (es) 2014-08-27
CA2863389A1 (en) 2013-08-08
US20140037759A1 (en) 2014-02-06
BR112014019155A8 (pt) 2017-07-11
HK1201179A1 (en) 2015-08-28
EP2809331A4 (en) 2015-07-15
EP2809331A1 (en) 2014-12-10
CO7020922A2 (es) 2014-08-11

Similar Documents

Publication Publication Date Title
CR20150174A (es) Composición esterilizada que comprende al menos un ácido hialuronico y ascorbil fosfato de magnesio
AR109170A2 (es) Esfingomielinasa ácida para uso en la prevención o el tratamiento de la enfermedad de niemann-pick a o b en un paciente
CO6400186A2 (es) Tabletas de acetato de ulipristal
NI201200189A (es) "composiciones farmacéuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona"
BR112012024673A2 (pt) composição anestésica termogelificante
ES2603070T3 (es) Aglutinante de aluminosilicato activado por álcali que contiene perlas de vidrio
RS54244B1 (en) NALBUFINE BASED FORMULATIONS AND THEIR USE
AR091351A1 (es) Formulaciones de bromocriptina, metodo para mejorar el control glucemico y metodo para la fabricacion
BR112015011430A2 (pt) composição para liberação imediata e prolongada
CL2016001094A1 (es) Silicato de zirconio microporoso para el tratamiento de hipercalemia.
AR092789A1 (es) Comprimido para beber bajo en calorias
CO6150126A2 (es) Formulaciones de comprimidos de liberacion inmediata de un antagonista del receptor de trombina
TR201004464A2 (tr) Kemik erimesi için formülasyon.
BR112012026453A2 (pt) lente melhorada para led
BR112013005440A2 (pt) "mistura de álcool de açúcar solidificada".
AR089857A1 (es) Comprimido antiacido para refrescar el aliento
CL2016002656A1 (es) Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor.
MX2015015681A (es) Composicion farmaceutica que comprende fingolimod.
PE20190321A1 (es) Composiciones farmaceuticas
ATE525064T1 (de) Pharmazeutische zusammensetzung mit desloratadin
ES2422281T3 (es) Granulado para la formulación de comprimidos bucodispersables
AR090169A1 (es) Aplicacion del modafinilo
RS53086B (en) OLMESARTAN PHARMACEUTICAL COMPOSITIONS
AR110957A1 (es) Agente terapéutico oral para tiroides
CR20190352A (es) Agente terapéutico oral tiroidal

Legal Events

Date Code Title Description
FB Suspension of granting procedure